LifeSiteNews.com

Monday December 3, 2001



SECOND BATCH OF SMALLPOX VACCINE USES ETHICAL ALTERNATIVE TO ABORTED BABY TISSUE


SHARE: E-mail E-MAIL  Print PRINT     

WASHINGTON, December 3, 2001 (LSN.ca) - Children of God For Life, the Internet's most reliable source for information on vaccines tainted by the use of aborted baby tissue, reports that the second batch of smallpox vaccine ordered November 28 by the United States will not use aborted fetal tissue in its manufacture. Whereas the first batch of the vaccine created by the Acambis Corporation used aborted fetal cell line MRC-5 as the cell substrate for growing the virus, the current batch of 155 million doses will use Vero animal cell lines. Acambis CEO John Brown stated in a conference earlier today, "The main difference is that in contract one, we are using the MRC-5 cell substrate; in contract two we're going to use the Baxter serum three Vero culture cell."

Debi Vinnedge, of Children of God for Life suggests that the change in vaccine is due to the response of pro-lifers who objected to the use of vaccines tainted with aborted baby tissue. The company said it would continue to use MRC-5 for the first 54 million doses ordered.

Carried on conservative news services in the US and in Canada only on LifeSite and Pro-Life E-News, the awareness of the tainted vaccines was able to generate public reaction which in turn was able to force consideration of an ethical alternative.

See LifeSite's earlier coverage:
http://www.lifesitenews.com/ldn/2001/nov/0111053 .html

See the Children of God for Life website at:
http://www.cogforlife.org/

Back to Top Back to Top

SHARE: E-mail E-MAIL  Print PRINT     



MORE NEWS: LifeSiteNews.com Home Page  Last 10 Days   Archives   Special Reports

Copyright © LifeSiteNews.com. This work is licensed under a Creative Commons Attribution-No Derivatives License. You may republish this article or portions of it without request provided the content is not altered and it is clearly attributed to "LifeSiteNews.com". Any website publishing of complete or large portions of original LifeSiteNews articles MUST additionally include a live link to www.LifeSiteNews.com. The link is not required for excerpts. Republishing of articles on LifeSiteNews.com from other sources as noted is subject to the conditions of those sources.